|1.||Xu, Chao: 1 article (01/2008)|
|2.||Zhao, Yumei: 1 article (01/2008)|
|3.||Sun, Ming: 1 article (01/2008)|
|4.||Supinski, Gerald S: 1 article (06/2006)|
|5.||Callahan, Leigh A: 1 article (06/2006)|
|6.||Hase, Makoto: 1 article (06/2005)|
|7.||Depre, Christophe: 1 article (06/2005)|
|8.||Vatner, Stephen F: 1 article (06/2005)|
|9.||Sadoshima, Junichi: 1 article (06/2005)|
|10.||Sternberg, Paul: 1 article (11/2004)|
|2.||Ganglion Cysts (Ganglion)
06/15/2001 - "Furthermore, DEVD-CHO, a tetrapeptide inhibitor for caspase-3 family members, reduced dramatically the fractin staining and significantly alleviated glutamate-induced cell death and DNA fragmentation in the ganglion cell layer and inner nuclear layer. "
04/06/1999 - "DEVD-CHO (Ac-Asp-Glu-Val-aspartic acid aldehyde) and DEVD-FMK (Z-Asp-Glu-Val-Asp-FMK), caspase inhibitors, when administered intraocularly at the time of optic nerve cut, at days 3 and 7 protect about 30-35% the ganglion cells from death. "
06/01/1998 - "The data indicate that alterations in expression of CD3-zeta and CD3-epsilon chains in T cells coincubated with OvCA are related to tumor-induced apoptosis, as the addition of pan-caspase inhibitors, DEVD-cho or YVAD-cho, prevents both the in vitro induction of T cell death by OvCA cells and the changes in the level of expression of CD3-zeta and CD3-epsilon chains. "
01/01/2000 - "Anti-apoptotic proteins Bcl-2, Bcl-XL and CrmA as well as peptide-inhibitors of caspases, DEVD-CHO and zVAD-FMK, failed to rescue tumor cells from Ad.asHsp70-induced cell death. "
06/01/2004 - "Moderating the severity of the insult by decreasing OGD exposure to 60 min did not reduce the amount of necrosis, but did induce a small degree of apoptosis (a slight reduction in cell death was observed in the presence of 10 uM DEVD-CHO). "
11/01/2004 - "Cell death was not prevented with either the broad-spectrum caspase inhibitor zVADfmk or the caspase 3-specific inhibitor DEVD-CHO, indicating that cytochrome bc1-mediated ROS production results in the MPT and necrosis. "
09/03/2003 - "Cultures treated with DEVD-CHO after preconditioning showed reduced PARP-1 cleavage and reduced resistance to subsequent ischemia. "
04/01/2003 - "Pre-perfusion with DEVD-CHO, an inhibitor of caspase-3-like proteases, completely prevented ischemia-induced DNA strand breaks, but only partially blocked cytochrome c release and mitochondrial respiratory inhibition. "
|1.||Caspase 3 (Caspase-3)
|2.||benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
|3.||Peptide Hydrolases (Proteases)
|4.||DNA (Deoxyribonucleic Acid)
|8.||Apoptosis Regulatory Proteins
|9.||Cytochromes c (Cytochrome c)